Computed Tomography and Ultrasound Contrast Agents

  • E. Edmund Kim


Contrast agent-assisted imaging of vasculature is widely employed during the diagnosis of many vascular and neoplastic diseases [1]. Conventional X-ray contrast media are ionic or neutral low molecular weight iodine-containing organic molecules and are able to delineate the vascular bed for a limited time following rapid extravasation into the interstitial space. Such a rapid disappearance of contrast material from the blood narrows the examination time window down to several minutes for the majority of diagnostic applications. Peak enhancement of the aorta takes place 10 to 20 s after the beginning of the injection. Within 2 min, the signal from the blood pool drops approximately fivefold [2].


Contrast Agent Focal Nodular Hyperplasia Ultrasound Contrast Agent Total Hepatic Blood Flow Giant Hemangioma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Curtin JJ, Mewissen MW, Crain MR, Lipchik RJ. Postcontrast CT in the diagnosis and assessment of response to thrombolysis in massive pulmonary embolism. J Comput Assist Tomogr 1994;18:133–137.PubMedCrossRefGoogle Scholar
  2. 2.
    Canty JM Jr, Judd RM, Brody AS, Klocke FJ. First-pass entry of nonionic contrast agent into the myocardial extravascular space: effects on radiographic estimates of transit time and blood volume. Circulation 1991;84:2071—2075.PubMedCrossRefGoogle Scholar
  3. 3.
    Daniels DL, Haughton VM, Williams AL. Computed tomography of the jugular foramen. AJNR 1983;4:1227–1232.Google Scholar
  4. 4.
    Blomley MJK, Coulden R, Bufkin C, et al. Contrast bolus dynamic computed tomography for the measurement of solid organ perfusion. Invest Radiol 1993;28:S72.CrossRefGoogle Scholar
  5. 5.
    Mattrey RF. Perfluorocytlbromide: a new contrast agent for CT, sonography and MRI. AJR 1989;152:247–251.PubMedCrossRefGoogle Scholar
  6. 6.
    Doucet D, Meyer D, Chambon C, Bonnemain B. Blood-pool X-ray contrast agents: evaluation of a new polymer. Invest Radiol 1991;26: S53.CrossRefGoogle Scholar
  7. 7.
    Ophir J, Parker KJ. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol 1989;15:319—327.PubMedCrossRefGoogle Scholar
  8. 8.
    Kudo M, Tomita S, Tochio H, et al. Sonography with intra-arterial infusion of carbon dioxide microbubbles: value in differential diagnosis of hepatic tumors. AJR 1992;158:65–74.PubMedCrossRefGoogle Scholar
  9. 9.
    Veltri A, Capello S, Faissola B, et al. Dynamic contrast-enhanced ultrasound with carbon dioxide microbubbles as adjunct to arteriography of liver tumors. Cardiovasc Intervent Radiol 1994;17:133–137.PubMedCrossRefGoogle Scholar
  10. 10.
    Leen E, Anderson JR, Robertson J, et al. Perfusion in the detection of hepatic metastases secondary to gastric carcinoma. Am J Surg 1997;173:99–102.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2001

Authors and Affiliations

  • E. Edmund Kim

There are no affiliations available

Personalised recommendations